Welcome to “Remember When Kids Just Died?” A daily two-part tour through every vaccine-preventable disease, starting with polio on September 1, 2026. Each disease gets two posts: the pre-vaccine era, when parents enjoyed the character-building experience of burying their children, and the post-vaccine era, when we ruined everything by making childhood survivable. Cramming both into one post felt disrespectful, to the corpses and the Nobel Prizes.
Congratulations, we ruined a great disease
If you want to understand what the Hib vaccine did, consider this: an entire generation of pediatricians has now finished residency without ever seeing a case of Hib epiglottitis. Not “rarely saw one.” Never. Zero.
Their attendings describe it the way grandparents describe rotary phones, and the residents nod politely while thinking about lunch.
Invasive Hib disease in the U.S. has declined by more than 99% from the pre vaccine era (CDC Pink Book). Ninety nine percent. In medicine, we throw parties over a 15% relative risk reduction with a hazard ratio that squints in the right direction. This was a bacterium that once caused about 20,000 cases a year in American children, and we deleted it from daily practice using a syringe and a sugar molecule glued to a protein (CDC Pink Book). Nobody made a movie about it. There’s no Oscar bait montage of a toddler not having a lumbar puncture.
The 1980s: version 1.0 was mediocre, which is the fun part
The first Hib vaccine, licensed in the mid 1980s, was a plain polysaccharide product, and it had one enormous flaw: it didn’t work well in the exact children who were dying, infants and young toddlers, whose immune systems look at bacterial sugar coatings and respond with total indifference (Peltola, Clinical Microbiology Reviews). Great vaccine. Wrong customers. So immunologists did something genuinely clever: they chemically attached the sugar to a carrier protein. Suddenly the infant immune system paid attention, because proteins are its native language.
Conjugate vaccines arrived by the late 1980s, infant schedules followed in 1990, and the epidemiologic curve fell off a cliff so fast that people initially assumed the surveillance was broken. That is the actual plot twist of this story: the first version underperformed, scientists redesigned it, and it worked. Which is how this is all supposed to go, despite what your cousin’s Facebook posts imply about the process being unfalsifiable magic.
The receipts, since somebody always asks
In U.S. surveillance areas, Hib incidence was 0.1 per 100,000 in 1997 and 0.02 per 100,000 by 2018 (CDC Pink Book). Compare that to a pre vaccine era where the rate in children under 5 ran 40 to 50 per 100,000 and roughly one in 200 children got invasive Hib before kindergarten (Peltola, Clinical Microbiology Reviews). In 2018, the entire United States, a country of 330 million people, reported 38 invasive Hib cases in children under 5 (CDC Pink Book). Thirty eight. That is fewer children than a well attended birthday party at a trampoline place.
The bonus round nobody promised
Here’s the part I find genuinely delightful. The vaccine doesn’t just protect the vaccinated child; it reduces carriage of Hib in the nose and throat, so vaccinated kids stop being a delivery service for their unvaccinated neighbors and their too young to vaccinate baby siblings (Peltola, Clinical Microbiology Reviews). The organism lost its transportation network. This is why unvaccinated children in highly vaccinated communities mostly don’t get Hib and then conclude the vaccine must be unnecessary. It’s the immunological equivalent of standing under someone else’s umbrella and announcing that rain is a hoax.
Who still gets it, and why it’s annoying
The remaining cases are the most frustrating chart review in pediatrics. Among the 36 Hib cases in U.S. children under 5 reported during 2009–2018: 12 were unvaccinated, 14 were undervaccinated, and 10 of those 14 had completed the primary series but never got the 12 through 15 month booster, while 2 were too young to be vaccinated at all (CDC Pink Book).
Read that again. A meaningful share of remaining Hib disease traces back to a missed booster appointment. Not a philosophical objection, not a vaccine failure, not a conspiracy. A rescheduled 12-month visit that never got rescheduled again. I have spent a nontrivial portion of my career trying to get families back in for that visit, and I want it on the record that “the vaccine schedule works if you actually finish it” is the least glamorous take in medicine and also completely correct.
Meanwhile, the genus is still out there
One clarification, because this trips people up: Haemophilus influenzae did not vanish. Invasive disease from the whole genus is actually reported more now than in the late 1990s, about 3,400 total invasive H. influenzae cases in 1997 versus 6,840 in 2018, but that’s driven by non-type b strains, mostly nontypeable, mostly in adults and older adults, and the vaccine was never claimed to cover those (CDC Pink Book).
Better surveillance and better serotyping also mean we simply count more of what was always happening (CDC surveillance manual).So when someone shares a screenshot showing “Haemophilus cases rising!” as evidence the vaccine failed, they’ve discovered that a type b vaccine prevents type b. Groundbreaking work. Nobel committee is standing by.
The unbearable dullness of victory
Successful vaccination programs have terrible public relations, because their product is an absence. There’s no patient to interview, no dramatic recovery, no telethon for the deafness that never developed and the funeral that didn’t happen. Just 38 cases a year in a country that used to have 20,000, and a bunch of pediatricians who have to look up epiglottitis management because they’ve never needed it. That’s the whole story.
The most exciting thing about Hib since 1984 is how profoundly, magnificently boring it became.Let’s keep it boring. Get the booster.
Sources:
Centers for Disease Control and Prevention. “Chapter 8: Haemophilus influenzae,” Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book). https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-8-haemophilus-influenzae.html
Peltola H. “Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century.” Clinical Microbiology Reviews. https://pmc.ncbi.nlm.nih.gov/articles/PMC100154/
Centers for Disease Control and Prevention. “Chapter 2: Haemophilus influenzae,” Manual for the Surveillance of Vaccine-Preventable Diseases. https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-2-haemophilus-influenzae.html